Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completed

Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

NCT05878327
unknown

Thrombophilia Screening After Severe IUGR

NCT05551078
unknown

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

NCT05068375
completed

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

NCT03148548

Clinical Trials (4)

Showing 4 of 4 trials
NCT05878327

Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

Completed
NCT05551078

Thrombophilia Screening After Severe IUGR

Unknown
NCT05068375

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

Unknown
NCT03148548

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4